SBIR/STTR Research Award
THE OBJECTIVE OF THIS CONTRACT IS TO DESIGN, SYNTHESIZE COMPOUNDS THAT BIND TO NEF, AN HIV ACCESSORY PROTEIN.
Award amount
$300,000Program and phase
SBIR · Phase IAward year
2021Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ZYMERON CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- GAMMMRQ6QMN1
- Solicitation number
- PHS2021-1
- Topic code
- 88
Research abstract
Therapeutic Targeting of Intracellular HIV-1 Proteins or Nucleic Acids: This research topic supports the development of therapeutics which target intracellular HIV proteins or nucleic acids (DNA, RNA) with the goal of inhibiting their function and ultimately HIV replication. The objective of this contract is to design and synthesize compounds that bind to Nef, an HIV accessory protein, which will be screened, selected and validated on their ability to degrade the Nef protein.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- An Automated Blood-in, miRNAs-out Assay to Detect Circulating and Exosome miRNAs
- Development of WoundShield for Pseudomonas aeruginosa-Caused Wounds Infections
- Omnidetect: a multiplexed portable detection platform enables culture-free enrichment and amplification to detect all types of foodborne pathogens
- Rapid Sample Processing Device to Support Battlefield Wound Infection Diagnostics
- Advanced portable low temperature plasma device for chronic wound disinfection and healing
Research funding history
42 SBIR/STTR records share this UEI (2017–2024). Reported award amounts total $24,710,238. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, Department of Health and Human Services, Department of Energy